Pharmacokinetics of levobupivacaine (2.5 mg/kg) after caudal administration in children younger than 3 years

Anesthesia and Analgesia

Volumn 107, Issue 4, 2008, Pages 1182-1184

  Cortínez, Luis I ^a,c   Fuentes, Ricardo ^a   Solari, Sandra ^a   Ostermann, Paola ^b   Vega, Miguel ^b   Muñoz, Hernán R ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Catholic University   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; LEVOBUPIVACAINE; PARACETAMOL; SEVOFLURANE; BUPIVACAINE; DRUG DERIVATIVE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; LOCAL ANESTHETIC AGENT;

ABDOMINAL SURGERY; ANESTHESIA INDUCTION; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; CAUDAL ANESTHESIA; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG TOXICITY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HUMAN; INFANT; INJECTION; MALE; MAXIMUM PLASMA CONCENTRATION; PATIENT MONITORING; PEDIATRIC SURGERY; POSTOPERATIVE ANALGESIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSE OXIMETRY; RECOVERY ROOM; TIME TO MAXIMUM PLASMA CONCENTRATION; VENOUS BLOOD;

ANESTHESIA, CAUDAL; ANESTHETICS, INHALATION; ANESTHETICS, LOCAL; BUPIVACAINE; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; METHYL ETHERS;

EID: 53449100132     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318181bb4d     Document Type: Article

References (11)

1. Foster RH, Markham A. Levobupivacaine: a review of its pharmacology and use as a local anaesthetic. Drugs 2000;59:551-79
2. Casati A, Putzu M. Bupivacaine, levobupivacaine and ropivacaine: are they clinically different? Best Pract Res Clin Anaesthesiol 2005;19:247-68
3. Bardsley H, Gristwood R, Baker H, Watson N, Nimmo W. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1998;46:245-9
4. Chalkiadis GA, Anderson BJ. Age and size are the major covariates for prediction of levobupivacaine clearance in children. Paediatr Anaesth 2006;16:275-82
5. Chalkiadis GA, Anderson BJ, Tay M, Bjorksten A, Kelly JJ. Pharmacokinetics of levobupivacaine after caudal epidural administration in infants less than 3 months of age. Br J Anaesth 2005;95:524-9
6. Chalkiadis GA, Eyres RL, Cranswick N, Taylor RH, Austin S. Pharmacokinetics of levobupivacaine 0.25% following caudal administration in children under 2 years of age. Br J Anaesth 2004;92:218-22
7. Smith RH. Safe dose of levobupivacaine (Chirocaine) in caudal analgesia in children. Br J Anaesth 2003;90:400-1
8. Astuto M, Disma N, Arena C. Levobupivacaine 0.25% compared with ropivacaine 0.25% by the caudal route in children. Eur J Anaesthesiol 2003;20:826-30
9. Buttner W, Finke W. Analysis of behavioural and physiological parameters for the assessment of postoperative analgesic demand in newborns, infants and young children: a comprehensive report on seven consecutive studies. Paediatr Anaesth 2000;10:303-18
10. Adams HA, Biscoping J, Ludolf K, Borgmann A, Bachmann MB, Hempelmann G. [The quantitative analysis of amide local anesthetics using high pressure liquid chromatography and ultraviolet detection (HPLC/UV)]. Reg Anaesth 1989;12:53-7
11. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med 2004;29:564 -75; discussion 24